Department of Pathology and Laboratory Medicine, Weill Cornell Medical College, New York, NY 10065; email:
Annu Rev Pathol. 2014;9:349-72. doi: 10.1146/annurev-pathol-012513-104656. Epub 2013 Oct 9.
Epstein-Barr virus (EBV) and Kaposi's sarcoma herpesvirus (KSHV), formally designated human herpesvirus 4 (HHV-4) and 8 (HHV-8), respectively, are viruses that can cause a variety of cancers in humans. EBV is found in non-Hodgkin and Hodgkin lymphomas, as well as in lymphoproliferative disorders, which occur more commonly but not exclusively in individuals with immunodeficiency. EBV also causes nonlymphoid malignancies such as nasopharyngeal carcinoma. KSHV causes primary effusion lymphomas, multicentric Castleman's disease, and Kaposi's sarcoma. The frequency of lymphoid malignancies related to infection by one of these two herpesviruses is greatly increased in individuals with immunodeficiency, whether primary or acquired, for example, as a consequence of HIV infection and AIDS or in the case of therapeutic immunosuppression for organ transplantation. Our current understanding indicates that EBV and KSHV contribute to lymphomagenesis by affecting genomic stability and by subverting the cellular molecular signaling machinery and metabolism to avoid immune surveillance and enhance tumor cell growth and survival. Understanding the viral associations in specific lymphoproliferative disorders and the molecular mechanisms of viral oncogenesis will lead to better prevention, diagnosis, and treatment strategies for these diseases.
爱泼斯坦-巴尔病毒(EBV)和卡波济肉瘤疱疹病毒(KSHV),分别正式命名为人类疱疹病毒 4(HHV-4)和 8(HHV-8),是能够在人类中引发多种癌症的病毒。EBV 存在于非霍奇金和霍奇金淋巴瘤以及淋巴增生性疾病中,这些疾病更常见但并非专门发生在免疫缺陷个体中。EBV 还会导致非淋巴样恶性肿瘤,如鼻咽癌。KSHV 会导致原发性渗出性淋巴瘤、多中心卡斯特曼病和卡波济肉瘤。在原发性或获得性免疫缺陷个体中,例如由于 HIV 感染和艾滋病,或在器官移植的治疗性免疫抑制情况下,与这两种疱疹病毒之一感染相关的淋巴恶性肿瘤的频率大大增加。我们目前的理解表明,EBV 和 KSHV 通过影响基因组稳定性和颠覆细胞分子信号机制和代谢来逃避免疫监视并增强肿瘤细胞生长和存活,从而促进淋巴瘤的发生。了解特定淋巴增生性疾病中的病毒关联以及病毒致癌的分子机制,将为这些疾病的更好预防、诊断和治疗策略提供指导。